Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Infection, 2024
Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals

Quek A., Wang S., Teng O. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Frontiers in Neurology, 2024
Role of inflammatory biomarkers in mediating the effect of lipids on spontaneous intracerebral hemorrhage: a two-step, two-sample Mendelian randomization study

Huang M., Liu Y., Cheng Y. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature Communications, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

Went M., Duran-Lozano L., Halldorsson G. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Cardio-Oncology, 2024
Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF

van den Berg P., Yousif L., Markousis-Mavrogenis G. et al.

Olink Target 96OncologyCVDPathophysiologyPatient StratificationPlasma

Journal of Proteome Research, 2024
Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank

Cao J., Zhuang M., Kong H. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Journal of Allergy and Clinical Immunology, 2024
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

Howell I., Yang F., Brown V. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasmaSputum

Cancer Science, 2024
Multiplex plasma protein assays as a diagnostic tool for lung cancer

Ahamed M., Forshed J., Levitsky A. et al.

Olink Target 96OncologyPatient StratificationPlasma

Nature Communications, 2024
Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease

Doostparast Torshizi A., Truong D., Hou L. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

European Journal of Heart Failure, 2024
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial

Tromp J., Lam C., Alemayehu W. et al.

Olink Target 96CVDPathophysiologyPlasma

eClinicalMedicine, 2024
Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial

Weng L., Wei L., Zhang Q. et al.

Olink Target 96ObstetricsPathophysiologyPlasma

Pediatric Obesity, 2024
Neurological‐related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity

Olvera‐Rojas M., Plaza‐Florido A., Solis‐Urra P. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma

Cardiovascular Research, 2024
Coronavirus disease 2019–related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities

Ćorović A., Zhao X., Huang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologySerum

CNS Neuroscience & Therapeutics, 2024
Shared genetics and causal association between plasma levels of SARSCoV‐2 entry receptor ACE2 and Alzheimer's disease

Zhang Y., Xu F., Wang T. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2024
Immune cell topography of head and neck cancer

Muijlwijk T., Nijenhuis D., Ganzevles S. et al.

Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium

Heliyon, 2024
Causal relationships between immune cells, inflammatory factors, serum metabolites, and hepatic cancer: A two-sample Mendelian randomization study

Chen H., Yang R., Zhang J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024
Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms

Villikudathil A., Mc Guigan D., English A.

Olink Target 96Metabolic DiseasesPatient StratificationData SciencePlasma

Diabetes Care, 2024
Large-Scale Proteomics Improve Prediction of Chronic Kidney Disease in People With Diabetes

Ye Z., Zhang Y., Zhang Y. et al.

Olink Explore 3072/384NephrologyPatient StratificationPlasma

Nature Medicine, 2024
Proteomic signatures improve risk prediction for common and rare diseases

Carrasco-Zanini J., Pietzner M., Davitte J. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Journal of Proteome Research, 2024
Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression

Yu S., Yang L., Shu J. et al.

Olink Target 96OncologyPathophysiologyPatient StratificationTissue Lysate

Archives of Dermatological Research, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo

Yamaguchi Y., Peeva E., Duca E. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

3119 publications